Akebia Therapeutics, Inc. (AKBA)
0.9517
+0.01
(+0.55%)
USD |
NASDAQ |
Sep 11, 16:00
0.9542
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Price : 0.9517 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 0.97 | 0.9828 | 0.9512 | 0.9517 | 6.141M |
| Sep 10, 2026 | 0.95 | 0.9677 | 0.9312 | 0.9465 | 4.922M |
| Sep 09, 2026 | 1.03 | 1.049 | 0.95 | 0.9539 | 4.880M |
| Sep 08, 2026 | 0.9616 | 1.03 | 0.9528 | 1.03 | 3.065M |
| Sep 04, 2026 | 0.988 | 0.9961 | 0.9471 | 0.9747 | 8.348M |
| Sep 03, 2026 | 0.9999 | 1.00 | 0.9615 | 0.9833 | 7.457M |
| Sep 02, 2026 | 0.95 | 1.01 | 0.9474 | 0.9803 | 12.86M |
| Sep 01, 2026 | 0.9099 | 0.9472 | 0.9099 | 0.9447 | 12.45M |
| Aug 31, 2026 | 0.88 | 0.9349 | 0.855 | 0.9188 | 15.18M |
| Aug 28, 2026 | 0.935 | 0.94 | 0.865 | 0.8786 | 10.19M |
| Aug 27, 2026 | 0.91 | 0.96 | 0.9056 | 0.9398 | 13.29M |
| Aug 26, 2026 | 0.957 | 0.957 | 0.8762 | 0.9065 | 14.03M |
| Aug 25, 2026 | 0.90 | 0.963 | 0.90 | 0.9584 | 11.34M |
| Aug 24, 2026 | 0.9078 | 0.9106 | 0.8722 | 0.9006 | 8.125M |
| Aug 21, 2026 | 0.9249 | 0.955 | 0.9054 | 0.9066 | 6.450M |
| Aug 20, 2026 | 0.88 | 0.9298 | 0.8722 | 0.9194 | 13.72M |
| Aug 19, 2026 | 0.8518 | 0.8977 | 0.85 | 0.8854 | 9.876M |
| Aug 18, 2026 | 0.8569 | 0.8626 | 0.8382 | 0.8518 | 1.955M |
| Aug 17, 2026 | 0.87 | 0.88 | 0.814 | 0.86 | 4.264M |
| Aug 14, 2026 | 0.87 | 0.8882 | 0.8581 | 0.8728 | 2.087M |
| Aug 13, 2026 | 0.9046 | 0.949 | 0.8641 | 0.8696 | 4.093M |
| Aug 12, 2026 | 0.8724 | 0.91 | 0.867 | 0.8932 | 4.555M |
| Aug 11, 2026 | 0.84 | 0.8849 | 0.84 | 0.8665 | 3.794M |
| Aug 10, 2026 | 0.90 | 0.909 | 0.8367 | 0.844 | 8.490M |
| Aug 07, 2026 | 0.961 | 0.962 | 0.8862 | 0.9099 | 10.93M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Emergent BioSolutions, Inc. | 6.23 |
| Exelixis, Inc. | 56.12 |
| ADMA Biologics, Inc. | 9.23 |
| Arcutis Biotherapeutics, Inc. | 23.88 |
| Relay Therapeutics, Inc. | 18.87 |
Price Related Metrics
| PS Ratio | 1.169 |
| Price to Book Value | 10.34 |
| Price to Free Cash Flow | 6.360 |
| Earnings Yield | -11.66% |
| Market Cap | 258.62M |